Organization
University Hospital Padova
1 clinical trial
Clinical trial
RAndomized Clinical Trial in COvid19 Patients to Assess the Efficacy of the Transmembrane Protease Serine 2 (TMPRSS2) Inhibitor NAfamostat (RACONA Study)Status: Recruiting, Estimated PCD: 2024-12-01